Sik‐Won Choi

943 total citations
46 papers, 788 citations indexed

About

Sik‐Won Choi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sik‐Won Choi has authored 46 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 21 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Sik‐Won Choi's work include Bone Metabolism and Diseases (30 papers), Bone health and treatments (19 papers) and NF-κB Signaling Pathways (8 papers). Sik‐Won Choi is often cited by papers focused on Bone Metabolism and Diseases (30 papers), Bone health and treatments (19 papers) and NF-κB Signaling Pathways (8 papers). Sik‐Won Choi collaborates with scholars based in South Korea, Japan and India. Sik‐Won Choi's co-authors include Seong Hwan Kim, Jeong‐Tae Yeon, Jaemin Oh, Myeung Su Lee, Young–Jin Son, Han Bok Kwak, Byung Jun Ryu, Kwang‐Jin Kim, Woo Duck Seo and Churl Hong Chun and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Sik‐Won Choi

45 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sik‐Won Choi South Korea 16 527 222 127 93 79 46 788
Fangming Song China 21 619 1.2× 225 1.0× 128 1.0× 138 1.5× 105 1.3× 49 948
Soo Woong Lee South Korea 11 488 0.9× 205 0.9× 97 0.8× 59 0.6× 120 1.5× 18 738
Yu Qian China 17 450 0.9× 116 0.5× 104 0.8× 84 0.9× 57 0.7× 37 703
Yoon‐Hee Cheon South Korea 16 407 0.8× 153 0.7× 84 0.7× 103 1.1× 87 1.1× 36 558
Zhanwang Xu China 13 429 0.8× 104 0.5× 116 0.9× 94 1.0× 80 1.0× 44 780
Franziska Busch Germany 7 405 0.8× 107 0.5× 126 1.0× 95 1.0× 127 1.6× 10 1.0k
Tsukasa Tominari Japan 18 317 0.6× 97 0.4× 55 0.4× 94 1.0× 73 0.9× 35 663
Fumiaki Shinohara Japan 16 569 1.1× 150 0.7× 87 0.7× 52 0.6× 72 0.9× 24 831
In‐Ryoung Kim South Korea 21 373 0.7× 108 0.5× 98 0.8× 101 1.1× 66 0.8× 53 1.0k
Naseer Ahmad India 16 375 0.7× 101 0.5× 67 0.5× 82 0.9× 95 1.2× 40 651

Countries citing papers authored by Sik‐Won Choi

Since Specialization
Citations

This map shows the geographic impact of Sik‐Won Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sik‐Won Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sik‐Won Choi more than expected).

Fields of papers citing papers by Sik‐Won Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sik‐Won Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sik‐Won Choi. The network helps show where Sik‐Won Choi may publish in the future.

Co-authorship network of co-authors of Sik‐Won Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Sik‐Won Choi. A scholar is included among the top collaborators of Sik‐Won Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sik‐Won Choi. Sik‐Won Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yang, Ji Yeong, et al.. (2023). Wheat seedling extract and its constituents attenuate RANKL-induced differentiation and fusion of osteoclasts and bone resorption. Applied Biological Chemistry. 66(1). 1 indexed citations
4.
Woo, So-Yeun, Kwang‐Sik Lee, Mi‐Ja Lee, et al.. (2020). Two new secondary metabolites isolated from Avena sativa L. (Oat) seedlings and their effects on osteoblast differentiation. Bioorganic & Medicinal Chemistry Letters. 30(14). 127250–127250. 8 indexed citations
5.
Choi, Sik‐Won, Han‐Jun Kim, Kwang‐Sik Lee, et al.. (2018). Germinated soy germ with increased soyasaponin Ab improves BMP-2-induced bone formation and protects against in vivo bone loss in osteoporosis. Scientific Reports. 8(1). 12970–12970. 16 indexed citations
6.
Choi, Sik‐Won, et al.. (2017). Barley Seedling Extracts Inhibit RANKL‐Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early‐to‐Late Stages of Osteoclastogenesis. Evidence-based Complementary and Alternative Medicine. 2017(1). 6072573–6072573. 14 indexed citations
7.
Choi, Won Jin, Sik‐Won Choi, Eun Hye Kim, et al.. (2016). Anti-cancer activity of ZnO chips by sustained zinc ion release. Toxicology Reports. 3. 430–438. 24 indexed citations
8.
Yeon, Jeong‐Tae, Sik‐Won Choi, & Seong Hwan Kim. (2015). Arginase 1 is a negative regulator of osteoclast differentiation. Amino Acids. 48(2). 559–565. 14 indexed citations
9.
Lee, Chang Hoon, Sik‐Won Choi, Ju‐Young Kim, et al.. (2015). Overexpression of prohibitin-1 inhibits RANKL-induced activation of p38-Elk-1-SRE signaling axis blocking MKK6 activity. Biochemical and Biophysical Research Communications. 463(4). 1028–1033. 5 indexed citations
10.
Choi, Sik‐Won, et al.. (2015). In vitro anti-osteoclastogenic activity of p38 inhibitor doramapimod via inhibiting migration of pre-osteoclasts and NFATc1 activity. Journal of Pharmacological Sciences. 129(3). 135–142. 13 indexed citations
11.
Choi, Sik‐Won, Su Ui Lee, Eun Hye Kim, et al.. (2015). Osteoporotic bone of miR-150-deficient mice: Possibly due to low serum OPG-mediated osteoclast activation. Bone Reports. 3. 5–10. 11 indexed citations
12.
Kim, Kwang‐Jin, Jeong‐Tae Yeon, Sik‐Won Choi, et al.. (2015). Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts. Bone. 81. 208–216. 33 indexed citations
13.
Choi, Sik‐Won, You Hwa Son, Sung Bum Park, et al.. (2014). A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation. Journal of Molecular Endocrinology. 52(2). 191–202. 22 indexed citations
14.
Choi, Sik‐Won, et al.. (2014). Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis. BMC Complementary and Alternative Medicine. 14(1). 35–35. 32 indexed citations
15.
Choi, Sik‐Won, Hye Kyoung Shin, Hsin‐Fang Yang‐Yen, et al.. (2014). Osteoclastogenic activity of translationally‐controlled tumor protein (TCTP) with reciprocal repression of p21. FEBS Letters. 588(21). 4026–4031. 3 indexed citations
16.
Yeon, Jeong‐Tae, Byung Jun Ryu, Sik‐Won Choi, et al.. (2014). Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways. Amino Acids. 46(11). 2605–2614. 14 indexed citations
17.
Choi, Sik‐Won, et al.. (2012). Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway. BMB Reports. 45(3). 171–176. 12 indexed citations
18.
Choi, Sik‐Won, et al.. (2012). VapB as a regulator of osteoclastogenesis via modulation of PLCγ2‐Ca2+‐NFAT signaling. FEBS Letters. 586(3). 263–269. 14 indexed citations
19.
Lee, Myeung Su, Jeong‐Tae Yeon, Sik‐Won Choi, et al.. (2009). GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway. The Journal of Immunology. 183(5). 3390–3399. 109 indexed citations
20.
Kwak, Han Bok, Jaemin Oh, Jeong‐Tae Yeon, et al.. (2009). Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression. Bone. 46(3). 724–731. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026